サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541034

サイトカイン市場レポート：サイトカインタイプ、治療用途、エンドユーザー、地域別、2024～2032年

Cytokine Market Report by Cytokine Type, Therapeutic Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 150 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
サイトカイン市場レポート：サイトカインタイプ、治療用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 150 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のサイトカイン市場規模は2023年に896億米ドルに達しました。今後、IMARC Groupは、市場が2032年までに1,633億米ドルに達し、2024～2032年の間に6.76%の成長率（CAGR）を示すと予測しています。

サイトカインとは、免疫系や血液細胞の増殖や活性を制御するために特定の細胞から放出されるタンパク質、ペプチド、糖タンパク質の一群を指します。高親和性ピコモル濃度であることから、免疫、炎症、造血を制御することができます。通常、化学療法の副作用の予防や管理、がんの治療に役立てるため、皮下または筋肉や静脈に注射されます。また、異常細胞を死滅させ、正常細胞を長生きさせるシグナルを送ることで、抗がん作用を高める。現在では、様々な種類の細胞の増殖や分化、生体外培養、その他の治療アプローチなど、細胞治療や遺伝子治療において広く採用されるようになってきています。

サイトカイン市場動向：

コロナウイルス感染症（COVID-19）は飛沫を介して感染し、炎症性サイトカインの過剰産生を誘導し、急性呼吸窮迫症候群（ARDS）の悪化や組織損傷を引き起こします。組織損傷は多臓器不全や死につながる可能性があるため、患者を管理し、生存率を向上させ、死亡率を減少させるためにサイトカインを標的とするソリューションに対する需要が高まっています。これとは別に、がんの有病率の増加と、術後の痛みや合併症が少なく回復が早い低侵襲手術（MIS）への需要の高まりが、市場の成長に寄与しています。さらに、サイトカインは健康や疾患の診断薬、予後予測薬、治療、バイオマーカーとして機能するため、免疫細胞の分化、炎症、血管新生、腫瘍形成、神経生物学、ウイルス病原体など、多様な機能で支持を集めています。これに加えて、アトピー性皮膚炎（AD）の患者数の増加は、激しい痒みを伴う再発性の慢性炎症性皮膚疾患であり、ADの病因における新規サイトカインへの需要と改善された治療標的の開発を促進しています。

本レポートで扱う主要質問

  • 世界のサイトカイン市場はこれまでどのように推移してきたか？
  • COVID-19は世界のサイトカイン市場にどのような影響を与えているか？
  • 主要地域市場とは？
  • サイトカインタイプ別の市場内訳は？
  • 治療用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要促進要因と課題は何か？
  • 世界のサイトカイン市場の構造と主要参入企業は？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のサイトカイン市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：サイトカインタイプ別

  • 腫瘍壊死因子-TNF
  • インターロイキン-II
  • インターフェロン-IFN
  • 上皮成長因子（EGF）
  • その他

第7章 市場内訳：治療用途別

  • がん
  • 喘息と気道の炎症
  • 関節炎
  • その他

第8章 市場内訳：エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 契約研究機関
  • 学術研究機関

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Abcam plc
    • Amgen Inc.
    • Applied Biological Materials Inc.（abm）
    • Bio-Techne Corporation
    • F. Hoffmann-La Roche AG
    • GenScript Biotech Corporation
    • Randox Laboratories Ltd.
    • Thermo Fisher Scientific Inc.
    • UCB S.A.
図表

List of Figures

  • Figure 1: Global: Cytokine Market: Major Drivers and Challenges
  • Figure 2: Global: Cytokine Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cytokine Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cytokine Market: Breakup by Cytokine Type (in %), 2023
  • Figure 5: Global: Cytokine Market: Breakup by Therapeutic Application (in %), 2023
  • Figure 6: Global: Cytokine Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Cytokine Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cytokine (Tumor Necrosis Factor-TNF) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Cytokine (Tumor Necrosis Factor-TNF) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Cytokine (Interleukins-Il) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Cytokine (Interleukins-Il) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Cytokine (Interferons-IFN) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cytokine (Interferons-IFN) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Cytokine (Epidermal Growth Factor-EGF) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Cytokine (Epidermal Growth Factor-EGF) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Cytokine (Other Cytokine Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Cytokine (Other Cytokine Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Cytokine (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Cytokine (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cytokine (Asthma and Airway Inflammation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cytokine (Asthma and Airway Inflammation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Cytokine (Arthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Cytokine (Arthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Cytokine (Other Therapeutic Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Cytokine (Other Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Cytokine (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Cytokine (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Cytokine (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Cytokine (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Cytokine Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Cytokine Industry: SWOT Analysis
  • Figure 82: Global: Cytokine Industry: Value Chain Analysis
  • Figure 83: Global: Cytokine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cytokine Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cytokine Market Forecast: Breakup by Cytokine Type (in Million US$), 2024-2032
  • Table 3: Global: Cytokine Market Forecast: Breakup by Therapeutic Application (in Million US$), 2024-2032
  • Table 4: Global: Cytokine Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Cytokine Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Cytokine Market: Competitive Structure
  • Table 7: Global: Cytokine Market: Key Players
目次
Product Code: SR112024A5891

The global cytokine market size reached US$ 89.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 163.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.76% during 2024-2032.

A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.

Cytokine Market Trends:

The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality. Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth. Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cytokine market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cytokine type, therapeutic application and end user.

Breakup by Cytokine Type:

Tumor Necrosis Factor-TNF

Interleukins-Il

Interferons-IFN

Epidermal Growth Factor-EGF

Others

Breakup by Therapeutic Application:

Cancer

Asthma and Airway Inflammation

Arthritis

Others

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Academic and Research Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.

Key Questions Answered in This Report:

  • How has the global cytokine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cytokine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cytokine type?
  • What is the breakup of the market based on the therapeutic application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cytokine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cytokine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cytokine Type

  • 6.1 Tumor Necrosis Factor-TNF
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Interleukins-Il
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Interferons-IFN
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Epidermal Growth Factor-EGF
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Therapeutic Application

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma and Airway Inflammation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Arthritis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Abcam plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Amgen Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Applied Biological Materials Inc. (abm)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Bio-Techne Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 GenScript Biotech Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Randox Laboratories Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Thermo Fisher Scientific Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 UCB S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials